Company intelligence / Profile preview

Ingerø Reiten Investment Company

Oslo, Oslo, Norway

Ownership: Private
Development stage: Other

Overview

Ingerø Reiten Investment Company (IRIC) is an Oslo-based investment and holding company focusing on various sectors. It is not directly involved in the pharmaceutical, biotech, or healthcare/life science sectors, though it has historically invested in such companies, notably holding a significant stake in Navamedic ASA until selling all shares in March 2024.

Industry: Investors

Beyond the preview

Go deeper on Ingerø Reiten Investment Company.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ingerø Reiten Investment Company.

Explore the full profile